A blue gradient background featuring a silhouette of a lion to the left of large capital letters “JVP,” evoking the bold atmosphere of a newsroom.

Sheba Medical Center Inks Strategic Agreement with Iguazio to Deliver Real-Time AI for COVID-19 Patient Treatment Optimization

December 16, 2020 09:00 AM Eastern Standard Time
HERZLIYA, Israel–(BUSINESS WIRE)–Iguazio, developers of the Data Science Platform built for production and real-time machine learning (ML) applications, announced that it is working with the Sheba Medical Center’s ARC innovation complex to deliver real-time AI across a variety of clinical and logistical use cases in order to improve COVID-19 patient treatment.

“After months of perfecting our AI research across many use cases, it’s time to bring them to life in our daily operations”

Tweet this

Sheba is the largest medical facility in Israel and the Middle East and has been ranked amongst the Top 10 Hospitals in the World by Newsweek magazine. Iguazio was selected to facilitate Sheba’s transformation with real-time AI and MLOps (machine learning operations) in a variety of projects. One of these projects is optimization of patient care through clinical, real-time predictive insights. Using the Iguazio Data Science Platform, Sheba is incorporating real-time vital signs from patients by utilizing the patient’s medical history to predict and mitigate complications such as COVID-19 patient deterioration or to aid decision making during surgery.

Another project optimizes the patient’s journey with smart mobility, from the moment of the patient’s arrival to Sheba as well as their departure after treatment. The patient’s entire journey is orchestrated with AI, including: parking allocation, shuttle arrival times, patient routing and waiting, with times optimized using real-time data to ensure optimal patient care and satisfaction. This also enables the management of patient flow to comply with COVID-19 social distancing regulations.

At the core of these projects is Iguazio’s cloud-native, serverless Data Science Platform with its integrated feature store. This technology brings data science to life by automating real-time machine learning pipelines and allowing rapid development, deployment and management of complex AI applications. The projects include collaboration on hybrid and multi-cloud deployments with Microsoft Azure and Google GCP.

“Bringing real-time AI to every aspect of Sheba’s emerging City of Health is the next step in our digital transformation”, said Eyal Zimlichman MD, MSc, Sheba’s Chief Medical Officer and Chief Innovation Officer, as well as the founder of the ARC (Accelerate Redesign Collaborate) innovation complex. “After months of perfecting our AI research across many use cases, it’s time to bring them to life in our daily operations”.

“Using Iguazio, we are revolutionizing the way we use data, by unifying real-time and historic data from different sources and rapidly deploying and monitoring complex AI models to improve patient outcomes and the City of Health’s efficiency”, added Nathalie Bloch, MD, Head of Big Data & AI at ARC.

“We are honored to be supporting Sheba, a global leader in healthcare innovation, especially in the midst of the current pandemic, when the community is relying on health facilities the most”, commented Asaf Somekh, Co-Founder and CEO of Iguazio. “Incorporating AI into these many real-time use cases is setting a new standard for medical centers worldwide”.

On Dec 30th, Sheba is hosting a Big Data and AI conference, where Asaf Somekh will present these projects and discuss how Sheba is bringing data science to life.

Medical centers worldwide are invited to get in touch with the ARC Innovation Center for more information and to discuss how to implement real-time AI in their health facilities.

Earlier today, Iguazio announced the launch of the first integrated feature store within their Data Science Platform to accelerate deployment of AI in any cloud environment

About Iguazio

The Iguazio Data Science Platform enables enterprises to develop, deploy and manage AI applications at scale. With Iguazio, enterprises can run AI models in real time, deploy them anywhere (multi-cloud, on-prem or edge), and bring to life their most ambitious AI-driven strategies. Enterprises spanning a wide range of verticals, including financial services, manufacturing, smart mobility, telecoms and ad-tech use Iguazio to solve the complexities of MLOps and create business impact through a multitude of real-time use cases such as fraud prevention, predictive maintenance and real-time recommendations. Iguazio is backed by top financial and strategic investors including Pitango, Samsung, Verizon, Bosch, CME Group, and Dell. Iguazio brings data science to life. Find out more on www.iguazio.com.

About Sheba Medical Center

Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East, which combines an acute care hospital and a rehabilitation hospital on one campus, and it is at the forefront of medical treatments, patient care, research, education and innovation. For the past two years (2019 and 2020), Newsweek Magazine has named Sheba one of the top ten hospitals in the world. For more information, visit: eng.sheba.co.il

Back to Press releases

Related posts

A blue gradient background featuring a silhouette of a lion to the left of large capital letters “JVP,” evoking the bold atmosphere of a newsroom.

Earnix Emerges as Category Leader in AI-Powered Insurance Transformation

startup.info
A blue gradient background featuring a silhouette of a lion to the left of large capital letters “JVP,” evoking the bold atmosphere of a newsroom.

ControlUp Leader in the 2025 Gartner® Magic Quadrant™ for DEX Management for Second Consecutive Year

Yahoo Finance
A blue gradient background featuring a silhouette of a lion to the left of large capital letters “JVP,” evoking the bold atmosphere of a newsroom.

Tech For Babies Is Booming. Here’s What One Parent Found Helped the Most.

The New York Times

A Defining Moment for Cybersecurity, for JVP, and for Israel/US Cooperation: CyberArk’s $25B Merger with Palo Alto Networks

Blue lion silhouette facing left beside bold blue letters “JVP” on a transparent background.

Last week marked a moment of both pride and reflection for all of us at JVP. The announcement of CyberArk’s $25 billion acquisition by Palo Alto Networks is not just a landmark deal in the cybersecurity landscape—it’s a powerful validation of the JVP Way, our approach to company building that continues to define our firm today.

While we are no longer CyberArk shareholders, having exited our position a few years after its IPO, we were proud to have been CyberArk’s leading and largest shareholder from its early days to several years after it became a public company and its emergence as an international category leader. While I was Chairman of the company, we partnered closely with the founders during the most formative years of its journey. Back in 2011, when many investors were ready to sell the company for $120 million, JVP chose to reinvest and increased our position to 47%, buying out early shareholders, bringing in Goldman Sachs as an equity investment partner, and partnering with management to lay the foundation for a strong international expansion. That pivotal moment gave the company the opportunity to scale into a true global market leader. 

CyberArk has always been ahead of the curve—pioneering insider threat protection, secrets management, machine-to-machine authentication, and most recently, preparing the world for secure Agentic-AI infrastructure. Its merger with Palo Alto Networks positions it to lead the AI era with a fully integrated, end-to-end security platform. 

We invite you to revisit JVP’s unique role in CyberArk’s growth in this Forbes featureReuters press, and from CyberArk’s newsroom.

This milestone is a reminder that JVP’s tried and true approach – invest, reinvest, roll up our sleeves, and work diligently alongside founders and management teams to build category leading global companies – works. The JVP Way, developed over 30 years, is what enables JVP to build companies that lead and transform industries to the benefit of our investors.

Today, we continue to apply the same methodology to our current portfolio with company after company surpassing the $100 million revenue threshold, with JVP owning 40% or more, as they too become category-leading international businesses.